Clal Biotechnology Industries Ltd (CBI) — Capital Reinvestment Ratio

Latest as of September 2020: 0.73x

Clal Biotechnology Industries Ltd (CBI) has a Capital Reinvestment Ratio of 0.73x as of September 2020, meaning it reinvests 1% of its operating cash flow (ILA1.10 Million) in capital expenditures (ILA806.00K). See cash generation quality of Clal Biotechnology Industries Ltd to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.73x

Capex / Operating Cash Flow

Operating Cash Flow

ILA1.10 Million

ILA

Capital Expenditures

ILA806.00K

ILA

Data as of

Sep 2020

Most recent filing

Clal Biotechnology Industries Ltd Capital Reinvestment Ratio (2019–2019)

This chart tracks Clal Biotechnology Industries Ltd's Capital Reinvestment Ratio across 1 annual periods.

Annual Capital Reinvestment Ratio for Clal Biotechnology Industries Ltd (2019–2019)

Year-by-year Capital Reinvestment Ratio for Clal Biotechnology Industries Ltd from 2019 to 2019. For live market cap and broader valuation context, see how much is Clal Biotechnology Industries Ltd worth.

Year	Reinvestment Ratio	Operating CF (ILA)	Capital Expenditures	YoY Change
2019	0.10x	ILA27.03 Million	ILA2.83 Million	—

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow